FluoroPharma Medical, Inc. (OTCMKTS:FPMI – Get Free Report) passed above its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $0.00 and traded as high as $0.00. FluoroPharma Medical shares last traded at $0.00, with a volume of 0 shares changing hands.
FluoroPharma Medical Stock Performance
FluoroPharma Medical Company Profile
FluoroPharma Medical, Inc, a biopharmaceutical company, engages in the discovery, development, and commercialization of molecular imaging pharmaceuticals with initial applications in the area of cardiology in the United States. Its product candidates include BFPET, an imaging agent that has completed a Phase I clinical trial in stress-testing for patients with presumptive or proven coronary artery disease (CAD); and CardioPET, a molecular imaging agent, which is in Phase IIa clinical trial to assess myocardial blood flow and metabolism in patients with CAD.
Featured Stories
- Five stocks we like better than FluoroPharma Medical
- 3 Best Fintech Stocks for a Portfolio Boost
- Merck: 4 No-Brainer Reasons to Buy This Dip
- The Most Important Warren Buffett Stock for Investors: His Own
- Ackman Announces Major Stake in Uber: Should You Follow His Lead?
- Roth IRA Calculator: Calculate Your Potential Returns
- Wells Fargo Upgraded These 3 Stocks—Here’s Why They Stand Out
Receive News & Ratings for FluoroPharma Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for FluoroPharma Medical and related companies with MarketBeat.com's FREE daily email newsletter.
